IntelliSep® Sepsis Test
Rapid assessment of sepsis probability

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
IntelliSep provides physicians key new information that may support the rapid, confident triage of patients
New findings from ADLM 2025: Cytovale’s rapid sepsis test boosts safe ED discharges by 56%
Multicenter study shows IntelliSep enables an increase in safe ED discharges, easing inpatient bed shortages without increasing 30-day return visits
Cytovale’s rapid diagnostic slashes sepsis mortality by 39%, peer-reviewed study confirms
Cytovale’s IntelliSep sepsis test highlights a new model for ED triage that’s already delivering systemwide clinical and economic value
Clinical Diagnostics Scientists’ Choice Awards winners announced at ADLM 2024
Thermo Fisher Scientific, Beckman Coulter Clinical Diagnostics, and LGC Clinical Diagnostics among those recognized



















